Home > PB Ratio > ERIS LIFESCIENCES

ERIS LIFESCIENCES
PB (Price/Book ) Ratio

The Current P/B Ratio of ERIS LIFESCIENCES is 7.26.

Share Price ₹1,376.2Nov 22,2024
Market Cap ₹18,729.4 Cr
Book Value₹2,581.1 CrMar2024 - Consolidated Results
Price/Book 7.26xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for ERIS LIFESCIENCES
Please provide your vote to see the results
ERIS LIFESCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of ERIS LIFESCIENCES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of ERIS LIFESCIENCES is calculated as :

Current Market Cap [ ₹18,729.4 Cr] as on Nov 22,2024

(/) Book Value [ ₹2,581.1 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 7.26x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for ERIS LIFESCIENCES , the investors are currently willing to pay '7.26 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of ERIS LIFESCIENCES !

The chart below summarizes the trend in P/B Ratio of ERIS LIFESCIENCES over the last five years.

Historical PB (Price/Book ) ratio chart of ERIS LIFESCIENCES


PB Ratio Performance Analysis for ERIS LIFESCIENCES

- ERIS LIFESCIENCES 's latest p/b ratio is 7.26x.

- ERIS LIFESCIENCES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.40x.

- ERIS LIFESCIENCES 's operated at median p/b ratio of 4.43x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ERIS LIFESCIENCES 's p/b ratio peaked in Mar2021 at 5.22x.

- ERIS LIFESCIENCES 's p/b ratio hit its five-year low in Mar2023 of 3.55x.


How does ERIS LIFESCIENCES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
ERIS LIFESCIENCES 2,581.107.2618,729.4
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.78431,352.0
CIPLA LTD26,619.904.51120,035.0
DR REDDYS LABORATORIES LTD28,123.503.60101,286.0
ZYDUS LIFESCIENCES LTD19,829.504.8195,461.4
DIVIS LABORATORIES LTD13,571.0011.74159,265.0
MANKIND PHARMA LTD9,339.8410.95102,231.0
TORRENT PHARMACEUTICALS LTD6,856.1515.65107,306.0
LUPIN LTD14,175.806.6694,430.6
AUROBINDO PHARMA LTD29,842.802.3871,069.8
ABBOTT INDIA LTD3,658.7316.0958,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs ERIS LIFESCIENCES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.38x
Max industry PB 16.09x
Median industry PB 6.78x
Average industry PB 8.22x



You may also like the below Video Courses